India Approves Its First Dengue Vaccine, QDENGA, After DCGI Clearance The approval of Takeda's QDENGA vaccine marks a significant milestone in India's fight against dengue.
The country has long struggled with the disease, which affects millions worldwide and accounts for nearly one third of the global burden.
Dengue is a mosquito borne viral disease that thrives in environments characterized by rapid urbanization, climate change, and widespread mosquito breeding.